Professional Experience
Dr. Rohrberg has extensive professional experience in oncology, combining leadership, clinical care, and research. His roles have allowed him to shape modern cancer treatments and mentor the next generation of oncologists.
- Head of the Phase 1 Unit: Department of Oncology, Rigshospitalet, Copenhagen. Oversees early-phase clinical trials, ensuring patient safety and treatment innovation.
- Clinical Associate Professor: University of Copenhagen, Department of Clinical Medicine. Engages in teaching, research supervision, and development of oncology curricula.
- Medical Doctor: Rigshospitalet, Copenhagen (Since 2005). Provides comprehensive patient care for individuals with complex and advanced cancers.
- Mentorship: Supervises junior doctors, research trainees, and medical students, fostering clinical and scientific growth.
Academic Contributions
Dr. Rohrberg is a prolific researcher and educator, contributing significantly to the academic oncology community. His work integrates scientific inquiry with practical clinical applications to improve patient outcomes.
- Research Focus: Early-phase clinical trials, translational oncology, personalized medicine, patient-derived xenografts, and high-throughput cancer drug screening.
- Teaching: Supervises medical students, residents, and postdoctoral researchers, offering hands-on guidance in oncology research and clinical practice.
- Presentations: Frequently invited to present findings at international oncology conferences and workshops, sharing knowledge on novel cancer therapies and translational research.
Areas of Expertise
Dr. Rohrberg is recognized for his expertise in treating complex cancers, particularly those that require innovative and personalized approaches. His patient-centered strategies ensure tailored treatment plans that address both the clinical and personal needs of patients.
- Glioblastoma: Implements targeted therapy strategies informed by genomic profiling to optimize patient outcomes.
- Urothelial Tract Cancer: Develops individualized treatment plans based on genetic and molecular tumor characteristics.
- Solid Tumors: Specializes in early-phase clinical trials and research-driven treatment approaches for various solid malignancies.
Publications and Research
Dr. Rohrberg has contributed extensively to oncology literature, advancing knowledge in translational and precision medicine. His research helps guide clinical decision-making and informs new therapeutic strategies.
- Genomic Profiling in Glioblastoma: Evaluated implementation of genomic profiling as standard care to identify actionable targets and improve therapy outcomes.
- High-Throughput ImmunoHistoFluorescence Method: Developed innovative methods for protein expression analysis in tumor tissues, aiding precision oncology research.
- Copenhagen Prospective Personalized Oncology (CoPPO): Comprehensive profiling of over 2,000 patients to optimize individualized treatment plans and improve survival rates in phase I oncology trials.
Patient Care Philosophy
Dr. Rohrberg emphasizes a holistic and empathetic approach to patient care. He prioritizes clear communication, patient education, and shared decision-making to ensure patients feel supported and informed throughout their treatment journey.
- Compassionate Care: Focuses on understanding patient concerns and tailoring treatments to individual needs.
- International Patients: Offers consultations and treatment planning for patients traveling from abroad, providing support for complex cases.
- Cultural Sensitivity: Promotes inclusive care that respects diverse cultural backgrounds and personal preferences.
Professional Affiliations
Dr. Rohrberg maintains active memberships in prestigious national and international oncology organizations, reflecting his commitment to advancing cancer research and clinical practice.
- European Society for Medical Oncology (ESMO): Member contributing to research and development of clinical oncology standards.
- American Association for Cancer Research (AACR): Engages in global research collaborations and cancer innovation projects.
- National Tumor Board: Participates in weekly reviews of complex oncology cases, collaborating with multidisciplinary teams to determine optimal treatment strategies.
FAQs
- Is Dr. Kristoffer Staal Rohrberg, MD, PhD board-certified?
- Yes, Dr. Rohrberg is board-certified in oncology and clinical medicine in Denmark.
- What types of surgeries does he perform?
- Dr. Rohrberg specializes in early-phase clinical trials and translational oncology; he does not perform surgical procedures.
- Does he treat international patients?
- Yes, he offers consultations and personalized treatment planning for international patients seeking advanced oncology care.
- How long is the typical hospital stay?
- The length of stay depends on the clinical trial or treatment plan, ranging from a few days for routine evaluations to longer durations for intensive therapy participation.
- What languages does he speak?
- Dr. Rohrberg is fluent in Danish and English, enabling effective communication with both local and international patients.
- What is Dr. Rohrberg’s approach to patient care?
- He emphasizes empathy, clear communication, and patient education, ensuring patients are active participants in their treatment decisions.
- What are his research interests?
- His research focuses on early-phase clinical trials, translational oncology, personalized medicine, high-throughput drug screening, and patient-derived tumor models.
